Clinical trials recruiting in Campo Grande, Brazil
9
Recruiting trials
15
Conditions
Phase breakdown
Phase 3 5Phase 4 1Not applicable 3
Conditions recruiting in Campo Grande, Brazil
Recruiting trials in Campo Grande, Brazil
- A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
- Biperiden Trial for Epilepsy Prevention
- Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Neuroendocrine Carcinomas: Patient Journey And Treatment Outcomes In Latin America
- Onco-Genomas Brasil: Mapping Breast and Prostate Cancer in the Brazilian Public Health System
- Study That Will Evaluate the Brazilian Population With COPD.
- Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
- Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
- Vitamin K AntagonISt, Factor Xa Inhibitor or No Anticoagulation in Atrial Fibrillation and DIalytic End-stage Renal DiseasE (VISIONAIRE)
Common questions
How many clinical trials are recruiting in Campo Grande, Brazil?
9 recruiting trials have at least one study site in Campo Grande, Brazil.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.